Search

Your search keyword '"Galderma International S.A.S. [Paris, France]"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Galderma International S.A.S. [Paris, France]" Remove constraint Author: "Galderma International S.A.S. [Paris, France]"
12 results on '"Galderma International S.A.S. [Paris, France]"'

Search Results

1. The conventional protocol versus a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, non-inferiority clinical study

2. A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGF alpha-Mediated Recruitment of Neutrophils

3. Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the non-inferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp

4. Topical Ivermectin 10~mg/g and Oral Doxycycline 40~mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments

5. High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity

6. Potential involvement of chemicals in liver cancer progression: An alternative toxicological approach combining biomarkers and innovative technologies

7. Endosulfan decreases cell growth and apoptosis in human HaCaT keratinocytes: partial ROS-dependent ERK1/2 mechanism

8. Activation of alpha- and beta-estrogen receptors by persistent pesticides in reporter cell lines

9. Effects of organochlorine insecticides on MAP kinase pathways in human HaCaT keratinocytes: Key role of reactive oxygen species

10. Activation of retinoic acid receptor-dependent transcription by organochlorine pesticides

11. Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy.

12. Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.

Catalog

Books, media, physical & digital resources